Ajanta Pharma shares gain after Jefferies initiates coverage with 'Buy' call, sees 11% upside

featured-image

Jefferies initiated coverage with a 'Buy' rating and a target price of Rs 2,850, citing strong execution, a focused branded generics strategy, and robust earnings growth..